← Scroll for more →
Quest Diagnostics Inc (DGX)
Services-Medical Laboratories
Latest Price
$251.82
TTM P/E
25.08
Normalized P/E
29.37
TTM Div Yield
1.34%
Fwd Div Yield
1.34%
Book Value
69.15
P/B Ratio
3.64
Valuation metrics
adjust assumptions →EPS: $8.75
Book value / share: $65.18
Formula: √(22.5 × EPS × BVPS)
Graham Number
$113.28
55% downside
Norm. op. income: $1.4B (median of 7yr)
Tax rate: 23%
Discount rate: 10%
Growth assumption: zero (EPV is a no-growth value)
Earnings Power Value
$52.26
79% downside
Base FCF: $1.3B (median of recent 5yr)
Growth: 10%/yr (median YOY, capped at 25%)
Discount rate: 10%
Terminal growth: 3%
Projection horizon: 10 years
DCF Fair Value
$253.25
+1% upside
EPS: $8.75
Target P/E: 29×
Formula: EPS × P/E
P/E Fair Value
$253.75
+1% upside
Institutional Ownership
93.9% held by institutions| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| BlackRock, Inc. | 9.28M | $1.97B | 8.43% | +103.1K | 2026-06-30 |
| Vanguard Capital Management LLC | 7.23M | $1.53B | 6.58% | +87.7K | 2026-06-30 |
| Vanguard Portfolio Management LLC | 6.13M | $1.30B | 5.57% | +49.6K | 2026-06-30 |
| State Street Corp | 5.52M | $1.17B | 5.02% | +135.8K | 2026-06-30 |
| Price T Rowe Associates Inc | 5.44M | $1.15B | 4.95% | -853.0K | 2026-06-30 |
| Boston Partners | 4.74M | $1.00B | 4.31% | +732.2K | 2026-06-30 |
| JPMorgan Chase & Co | 3.52M | $748.0M | 3.20% | -625.5K | 2026-06-30 |
| Geode Capital Management, LLC | 3.14M | $662.0M | 2.85% | +51.6K | 2026-06-30 |
| Morgan Stanley | 2.46M | $521.0M | 2.24% | -19.2K | 2026-06-30 |
| EdgePoint Investment Group Inc. | 2.25M | $476.0M | 2.04% | +3.7K | 2026-06-30 |